Hasnain Faheem insider trades
Hasnain Faheem has filed 28 Form 4s with the SEC that we hold, for Gossamer Bio, Inc. (GOSS) (President & CEO, Director), Kura Oncology, Inc. (KURA) (Director) and MRTX (Director). Across all of them we count 6 purchases worth $2.5M and 4 sales worth $487.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($109.8K). The largest single trade was a purchase of 138,696 shares of Gossamer Bio, Inc. worth $1.0M, dated 2022-07-15. The first filing on our record is dated 2022-01-10 and the latest 2026-08-26.
Gossamer Bio, Inc. (GOSS)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-03-23 | S, sale reported on Form 4 | 19,035 | $169.8K | 2022-03-24 | SEC |
| 2022-07-15 | P, purchase reported on Form 4 | 138,696 | $1.0M | 2022-07-15 | SEC |
| 2023-03-20 | P, purchase reported on Form 4 | 168,683 | $173.7K | 2023-03-22 | SEC |
| 2023-03-21 | P, purchase reported on Form 4 | 269,389 | $323.3K | 2023-03-22 | SEC |
| 2023-03-22 | P, purchase reported on Form 4 | 440,500 | $502.2K | 2023-03-22 | SEC |
| 2024-03-27 | S, sale reported on Form 4 | 23,172 | $26.9K | 2024-03-28 | SEC |
| 2024-06-21 | P, purchase reported on Form 4 | 372,000 | $249.2K | 2024-06-24 | SEC |
Kura Oncology, Inc. (KURA)
MRTX
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-08-11 | P, purchase reported on Form 4 | 10,791 | $300.0K | 2023-08-14 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1352620) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
